Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q1 2024 (March 31)3holders
1famous investor
$0.05avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings. The largest holders were Citadel Advisors ($3K), Clear Street LLC ($91) and UBS Group AG ($2). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $30 |
Ownership 3 holders
| Citadel Advisors | — | Add +8.9% | 67,115 | $3K |
| Clear Street LLC | — | Reduce -9.6% | 1,876 | $91 |
| UBS Group AG | — | Reduce -60.6% | 39 | $2 |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.